American Journal of Ophthalmology
Volume 143, Issue 5 , Pages 840-846.e2 , May 2007

Juvenile Idiopathic Arthritis-Associated Uveitis: Incidence of Ocular Complications and Visual Acuity Loss

  • Jennifer E. Thorne

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Epidemiology, Center for Clinical Trials, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
    • Corresponding Author InformationInquiries to Jennifer E. Thorne, Wilmer Eye Institute, 550 North Broadway, Suite 700, Baltimore, MD 21205
  • ,
  • Fasika Woreta

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Sanjay R. Kedhar

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • James P. Dunn

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Douglas A. Jabs

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Epidemiology, Center for Clinical Trials, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.

,Accepted 12 January 2007.

References 

  1. Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2003;14:395–398
  2. Kotaniemi K, Savolainen A, Karma A, Aho K. Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol. 2003;48:489–502
  3. Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–392
  4. Ravelli A, Felici E, Magni-Manzoni S, et al. Patients with anti-nuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum. 2005;52:826–832
  5. Key SN, Kimura SJ. Iridocyclitis associated with juvenile rheumatoid arthritis. Am J Ophthalmol. 1975;80:425–429
  6. Ozdal PC, Vianna RN, Deschenes J. Visual outcomes of juvenile rheumatoid arthritis–associated uveitis in adults. Ocul Immunol Inflamm. 2005;13:33–38
  7. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;104:236–244
  8. Kump LI, Cervantes Castaneda RA, et al. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology. 2006;113:1874–1877
  9. Yu EN, Meniconi ME, Tufail F, et al. Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis. Ocul Immunol Inflamm. 2005;13:353–360
  10. Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987;94:1242–1248
  11. Edelsten C, Lee V, Bentley CR, et al. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86:51–56
  12. Rosenberg AM, Oen KG. The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum. 1986;29:797–800
  13. Chen CS, Roberton D, Hammerton ME. Juvenile arthritis-associated uveitis: visual outcomes and prognosis. Can J Ophthalmol. 2004;39:614–620
  14. Chalom EC, Goldsmith DP, Koehler MA, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1997;24:2031–2034
  15. Zulian F, Martini G, Falcini F, et al. Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. J Rheumatol. 2002;29:2446–2253
  16. Chia A, Fraco , Lee V, Graham EM, Edelsten C. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003;135:757–762
  17. Woreta F, Thorne JE, Jabs DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis (JIA). Am J Ophthalmol. 2007;143:647–655
  18. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders. Am J Ophthalmol. 2000;130:492–513
  19. Jabs DA, Nussenblatt RB, Rosenbaum JT Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol. 2005;140:509–516
  20. Ferris FL, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91–96
  21. Diggle PJ, Liang KY, Zeger SL. In: Analysis of longitudinal data. Oxford, United Kingdom: Clarendon Press; 1994;p. 145–162
  22. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc. 1989;84:1074–1078
  23. Heiligenhaus A, Niewerth M, Mingels A, et al. Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database. Klin Monatsbl Augenheilkd. 2005;222:993–1001
  24. Davis JL, Dacanay LM, Holland GN, et al. Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol. 2003;135:763–771

PII: S0002-9394(07)00103-1

doi: 10.1016/j.ajo.2007.01.033

American Journal of Ophthalmology
Volume 143, Issue 5 , Pages 840-846.e2 , May 2007